If you liked this article you might like

Pharma Has History of Price Gouging, Mylan Should Be No Surprise
Pharmacy Benefit Managers Shouldn't Fret Initial Fallout from Mylan Fiasco
FTC Details Concerns on Generic Drug Company Mergers
Mylan Is Done Leaning on EpiPen Sales and That Could be a Big Problem